164 related articles for article (PubMed ID: 26839328)
1. Dermatotoxicology: Safety Evaluation of Topical Products in Minipigs: Study Designs and Practical Considerations.
Willard-Mack C; Ramani T; Auletta C
Toxicol Pathol; 2016 Apr; 44(3):382-90. PubMed ID: 26839328
[TBL] [Abstract][Full Text] [Related]
2. The minipig in dermatotoxicology: methods and challenges.
Mahl JA; Vogel BE; Court M; Kolopp M; Roman D; Nogués V
Exp Toxicol Pathol; 2006 Jul; 57(5-6):341-5. PubMed ID: 16713702
[TBL] [Abstract][Full Text] [Related]
3. The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Colleton C; Brewster D; Chester A; Clarke DO; Heining P; Olaharski A; Graziano M
Toxicol Pathol; 2016 Apr; 44(3):458-66. PubMed ID: 27006130
[TBL] [Abstract][Full Text] [Related]
4. The importance of minipigs in dermal safety assessment: an overview.
Stricker-Krongrad A; Shoemake CR; Liu J; Brocksmith D; Bouchard G
Cutan Ocul Toxicol; 2017 Jun; 36(2):105-113. PubMed ID: 27161161
[TBL] [Abstract][Full Text] [Related]
5. The minipig as nonrodent species in toxicology--where are we now?
Ganderup NC; Harvey W; Mortensen JT; Harrouk W
Int J Toxicol; 2012; 31(6):507-28. PubMed ID: 23134714
[TBL] [Abstract][Full Text] [Related]
6. The distribution of esterases in the skin of the minipig.
Jewell C; Prusakiewicz JJ; Ackermann C; Payne NA; Fate G; Williams FM
Toxicol Lett; 2007 Sep; 173(2):118-23. PubMed ID: 17719730
[TBL] [Abstract][Full Text] [Related]
7. Specificities of the Skin Morphology in Juvenile Minipigs.
Gauthier BE; Penard L; Bordier NF; Briffaux JJ; Ruty BM
Toxicol Pathol; 2018 Oct; 46(7):821-834. PubMed ID: 30348062
[TBL] [Abstract][Full Text] [Related]
8. Background Pathological Changes in Minipigs: A Comparison of the Incidence and Nature among Different Breeds and Populations of Minipigs.
Helke KL; Nelson KN; Sargeant AM; Jacob B; McKeag S; Haruna J; Vemireddi V; Greeley M; Brocksmith D; Navratil N; Stricker-Krongrad A; Hollinger C
Toxicol Pathol; 2016 Apr; 44(3):325-37. PubMed ID: 26534940
[TBL] [Abstract][Full Text] [Related]
9. The Use of Minipig in Drug Discovery and Development: Pros and Cons of Minipig Selection and Strategies to Use as a Preferred Nonrodent Species.
Heining P; Ruysschaert T
Toxicol Pathol; 2016 Apr; 44(3):467-73. PubMed ID: 26674804
[TBL] [Abstract][Full Text] [Related]
10. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.
Descotes J; Allais L; Ancian P; Pedersen HD; Friry-Santini C; Iglesias A; Rubic-Schneider T; Skaggs H; Vestbjerg P
Regul Toxicol Pharmacol; 2018 Apr; 94():271-275. PubMed ID: 29481836
[TBL] [Abstract][Full Text] [Related]
11. Dermal toxicity studies: factors impacting study interpretation and outcome.
Chandra SA; Stokes AH; Hailey R; Merrill CL; Melich DH; DeSmet K; Furst SM; Peterson RA; Mellon-Kusibab K; Adler RR
Toxicol Pathol; 2015 Jun; 43(4):474-81. PubMed ID: 25389277
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Minipigs in the Development of Anticancer Therapeutics: Species Comparison and Examples of Special Applications.
Mahl A; Dincer Z; Heining P
Toxicol Pathol; 2016 Apr; 44(3):391-7. PubMed ID: 26698323
[TBL] [Abstract][Full Text] [Related]
13. The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations.
Forster R; Bode G; Ellegaard L; van der Laan JW
J Pharmacol Toxicol Methods; 2010; 62(3):236-42. PubMed ID: 20685309
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and Electroretinographic Characterization of the Minipig Eye in the Context of Drug Safety Investigations.
Negro Silva LF; Li C; de Seadi Pereira PJB; Tan W; Dubuc-Mageau M; Sanfacon A; Forster R; Tavcar R; Makin A; Authier S
Int J Toxicol; 2019; 38(5):415-422. PubMed ID: 31470746
[TBL] [Abstract][Full Text] [Related]
15. Dermal absorption of mucopolysaccharide polysulfate (heparinoid) in human and minipig.
Kumokawa T; Hirata K; Sato K; Kano S
Arzneimittelforschung; 2011; 61(2):85-91. PubMed ID: 21428242
[TBL] [Abstract][Full Text] [Related]
16. Vehicle Systems and Excipients Used in Minipig Drug Development Studies.
Weaver ML; Grossi AB; Schützsack J; Parish J; Løgsted J; Bøgh IB; Cameron D; Harvey W; Festag M; Downes N; Venturella S; Schlichtiger J; Mhedhbi S; Ross V; Kissner T; Stark C; Milano S; Heining P; Sanchez-Felix M
Toxicol Pathol; 2016 Apr; 44(3):367-72. PubMed ID: 26674803
[TBL] [Abstract][Full Text] [Related]
17. Miniature Swine Breeds in Toxicology and Drug Safety Assessments: What to Expect during Clinical and Pathology Evaluations.
Stricker-Krongrad A; Shoemake CR; Pereira ME; Gad SC; Brocksmith D; Bouchard GF
Toxicol Pathol; 2016 Apr; 44(3):421-7. PubMed ID: 26656239
[TBL] [Abstract][Full Text] [Related]
18. Use of minipig skin biopsy model as an innovative tool to design topical formulation to achieve desired pharmacokinetics in humans.
Mitra A; Leyes A; Manser K; Roadcap B; Mestre C; Tatosian D; Jin L; Uemura N
J Pharm Sci; 2015 May; 104(5):1701-8. PubMed ID: 25691117
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Candidiasis in a Gottingen Minipig: A Potential Pitfall in Preclinical Studies.
Ramot Y; Obaya A; McNamara A; Nyska A
Toxicol Pathol; 2017 Dec; 45(8):1032-1034. PubMed ID: 28929952
[TBL] [Abstract][Full Text] [Related]
20. Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.
Jo W; Glynn M; Nejishima H; Sanada H; Minowa K; Calvarese B; Senda H; Pillai R; Mutter L
Regul Toxicol Pharmacol; 2014 Oct; 70(1):242-53. PubMed ID: 25038564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
